Published in Ann Intern Med on October 15, 1997
Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol (2005) 1.36
The future of scientific medicine. CMAJ (1998) 1.24
Dynamic microsimulation models for health outcomes: a review. Med Decis Making (2010) 1.18
Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2. Value Health (2012) 1.16
Combining information from multiple data sources to create multivariable risk models: illustration and preliminary assessment of a new method. J Biomed Biotechnol (2005) 1.05
Use of dynamic microsimulation to predict disease progression in patients with pneumonia-related sepsis. Crit Care (2007) 0.84
Comparative effectiveness and implementation research: directions for neurology. Ann Neurol (2012) 0.81
Validation of a decision model for preventive pharmacological strategies in postmenopausal women. Eur J Epidemiol (2005) 0.76
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA (2000) 12.27
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis (1997) 9.39
Discordance of databases designed for claims payment versus clinical information systems. Implications for outcomes research. Ann Intern Med (1993) 8.75
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol (1997) 6.10
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med (2001) 5.68
Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol (1991) 5.65
Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA (1997) 5.47
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease. Neurology (1997) 5.29
Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics (1999) 4.86
The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol (2000) 4.77
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med (2000) 4.73
A method for assessing drug therapy appropriateness. J Clin Epidemiol (1992) 4.36
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med (1993) 4.30
A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial. N Engl J Med (1984) 4.29
Inverse association of dietary fat with development of ischemic stroke in men. JAMA (1998) 4.20
Stroke severity in atrial fibrillation. The Framingham Study. Stroke (1996) 4.11
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Variability of body weight and health outcomes in the Framingham population. N Engl J Med (1991) 3.61
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med (1996) 3.53
Morning increase in onset of ischemic stroke. Stroke (1989) 3.52
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
Adverse drug events in high risk older outpatients. J Am Geriatr Soc (1997) 3.40
Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res (2000) 3.39
Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA (1995) 3.27
Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology (2010) 3.27
Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord (2003) 3.23
Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol (1989) 3.13
Inflammatory markers and the risk of Alzheimer disease: the Framingham Study. Neurology (2007) 3.12
The Stroke Data Bank: design, methods, and baseline characteristics. Stroke (1988) 3.12
Structure and function of helix-loop-helix proteins. Biochim Biophys Acta (1994) 3.06
Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study. Neurology (2004) 2.97
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91
The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg (1993) 2.91
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87
What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke (1996) 2.84
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81
Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst (1997) 2.80
Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med (1992) 2.77
Noninvasive carotid artery testing. A meta-analytic review. Ann Intern Med (1995) 2.75
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. Biometrics (1992) 2.70
Clustering of metabolic factors and coronary heart disease. Arch Intern Med (1999) 2.69
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol (1993) 2.67
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Ann Intern Med (2000) 2.65
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology (1992) 2.64
Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med (1988) 2.62
The burden of illness of cancer: economic cost and quality of life. Annu Rev Public Health (2001) 2.59
Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol (2001) 2.57
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med (2000) 2.54
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Protective effect of fruits and vegetables on development of stroke in men. JAMA (1995) 2.50
Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. AJR Am J Roentgenol (2000) 2.49
Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J (1996) 2.47
Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med (1999) 2.44
A nurse-coordinated intervention for primary care patients with non-insulin-dependent diabetes mellitus: impact on glycemic control and health-related quality of life. J Gen Intern Med (1995) 2.44
Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. Neurology (1997) 2.43
The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol (1995) 2.42
Bacterial indicators of risk of diarrhoeal disease from drinking-water in the Philippines. Bull World Health Organ (1991) 2.42